Catalyst
Slingshot members are tracking this event:
Kite Expects Investigational New Drug Application in 2018 for KTE-439 in Cervical Cancer and Head and Neck Cancer
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| KITE |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 02, 2018
Occurred Source:
https://www.gilead.com/news/press-releases/2018/10/kite-and-hifibio-therapeutics-announce-a-research-collaboration-to-develop-technology-for-the-potential-discovery-of-neoantigenreactive-t-cell-receptors-tcrs-for-the-treatment-of-cancer
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Investigational New Drug Application, Kte-439, Cervical Cancer, Head And Neck Cancer
